These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1015210)
1. Usefulness of piracetam in intensive care. Godard JP; Goerens C; Grelier C Acta Anaesthesiol Belg; 1976; 27 suppl():115-22. PubMed ID: 1015210 [No Abstract] [Full Text] [Related]
2. [Therapeutic effects of Nootropyl]. Houillon P; Kitenge A; Jouannigot R; Lullien L Ann Med Psychol (Paris); 1980; 138(7):869-76. PubMed ID: 7458110 [No Abstract] [Full Text] [Related]
3. [Use of bamethan in the emergency treatment of cerebral disorders]. Lotto A; Cantono GM; Cavallaro GF Arch Sci Med (Torino); 1971; 128(4):210-20. PubMed ID: 4404000 [No Abstract] [Full Text] [Related]
4. [Effect of piracetam on cerebral hemodynamics in patients with arteriosclerosis and dyscirculatory encephalopathy]. Vesel'skiĭ ISh; Voroniuk MI Klin Med (Mosk); 1986 Jun; 64(6):41-4. PubMed ID: 3747435 [No Abstract] [Full Text] [Related]
5. [Use of piracetam (nootropil) on alcoholism patients under ambulatory control of withdrawal manifestations]. Entin GM Sov Med; 1981; (5):109-11. PubMed ID: 7268522 [No Abstract] [Full Text] [Related]
6. [Use of piracetam (nootropil) in the rehabilitative treatment of the middle-aged and elderly who have had a stroke]. Man'kovskiĭ NB; Kostiuchenko VG; Tereshchenko LA; Tordiia GD Vrach Delo; 1980 Sep; (9):73-7. PubMed ID: 7423958 [No Abstract] [Full Text] [Related]
7. [Cognitive function in alcoholics in a double-blind study of piracetam]. Buranji I; Skocilić Z; Kozarić-Kovacić D Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773 [TBL] [Abstract][Full Text] [Related]
8. [Effect of piracetam on the brain-organic psychosyndrome in cerebrovascular insufficiency. Results of a double-blind study in 40 cases]. Trabant R; Poljakovic Z; Trabant D Ther Ggw; 1977 Aug; 116(8):1504-21. PubMed ID: 331549 [No Abstract] [Full Text] [Related]
9. [Piracetam in premature biological aging. Double-blind study after preselection by drugs]. Dorn M Fortschr Med; 1978 Aug; 96(30):1525-30. PubMed ID: 669550 [No Abstract] [Full Text] [Related]
10. [Effect of cytidine monophosphate on organic syndromes of the brain]. Otsuki S; Ninomiya K; Yamamoto M; Nakashima Y; Shutara M No To Shinkei; 1966 Jul; 18(7):745-9. PubMed ID: 5953682 [No Abstract] [Full Text] [Related]
12. [Effect of piracetam on the functional activity of the brain in patients with craniocerebral injuries]. Sharova EV; Potapov AA; Kulikov MA Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):42-8. PubMed ID: 3137753 [TBL] [Abstract][Full Text] [Related]
13. [Effect of piracetam on some manifestations of the effects of ethanol and acetaldehyde]. Vikhliaev IuI; Artemenko GN; Voronina TA; Ul'ianova OV; Nerobkova LN Farmakol Toksikol; 1979; 42(1):76-81. PubMed ID: 570515 [TBL] [Abstract][Full Text] [Related]
14. [Personal experience with the use of piracetam (Nootropil) in anesthesiology]. Zaffiri O; Marchetti G; Vignotto F; Bonardi C; Scarella MR Minerva Anestesiol; 1977 Mar; 43(3):201-2. PubMed ID: 854202 [No Abstract] [Full Text] [Related]
15. Piracetam and chlormethiazole in acute alcohol withdrawal: a controlled clinical trial. Dencker SJ; Wilhelmson G; Carlsson E; Bereen FJ J Int Med Res; 1978; 6(5):395-400. PubMed ID: 359384 [TBL] [Abstract][Full Text] [Related]
16. [Metabolic study of piracetam in neurosurgical resuscitation]. Roquefeuil B; Escuret E; Viguié E Agressologie; 1975; 16(1):43-62. PubMed ID: 1232798 [No Abstract] [Full Text] [Related]
17. [Use of piracetam in the treatment of cranial injuries. Observations on 903 cases]. Cicerchia G; Santucci R; Palmieri M Clin Ter; 1985 Sep; 114(6):481-7. PubMed ID: 3905223 [No Abstract] [Full Text] [Related]
18. Myoclonus, delayed sequelae of carbon monoxide poisoning, piracetam trial. Kim JS; Lee SA; Kim JS Yonsei Med J; 1987; 28(3):231-3. PubMed ID: 3433813 [No Abstract] [Full Text] [Related]
19. [Effect of nootropic agents on the brain bioelectrical activity and on the indices of neuromediator metabolism in the acute period of severe craniocerebral trauma]. Madorskiĭ SV; Potapov AA; Piasetskaia MV; Shapova EV; Il'icheva RF Zh Vopr Neirokhir Im N N Burdenko; 1989; (3):29-35. PubMed ID: 2572097 [TBL] [Abstract][Full Text] [Related]
20. [On the therapeutical effect of a brain-hydrolisate from a point of view of the clinic and the animal experimentations (author's transl)]. Sommer H; Harrer G Folia Clin Int (Barc); 1973 Sep; 23(9):598-615. PubMed ID: 4805352 [No Abstract] [Full Text] [Related] [Next] [New Search]